The former inhibits the cytokine storm caused by TLR pathways [52], whereas the latter promotes apoptosis in CLL cells via TLR-7 and TLR-9 both in vitro and in vivo [53,54]. The gene discussed is TLR7; the disease is B-cell chronic lymphocytic leukemia.